Your browser doesn't support javascript.
loading
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.
Gordon, Khloe S; Kyung, Taeyoon; Perez, Caleb R; Holec, Patrick V; Ramos, Azucena; Zhang, Angela Q; Agarwal, Yash; Liu, Yunpeng; Koch, Catherine E; Starchenko, Alina; Joughin, Brian A; Lauffenburger, Douglas A; Irvine, Darrell J; Hemann, Michael T; Birnbaum, Michael E.
Afiliação
  • Gordon KS; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Kyung T; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Perez CR; Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Holec PV; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Ramos A; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Zhang AQ; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Agarwal Y; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Liu Y; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Koch CE; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Starchenko A; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Joughin BA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Lauffenburger DA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Irvine DJ; Department of Health, Science, and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Hemann MT; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
  • Birnbaum ME; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Biomed Eng ; 6(7): 855-866, 2022 07.
Article em En | MEDLINE | ID: mdl-35710755
ABSTRACT
The immunostimulatory intracellular domains (ICDs) of chimaeric antigen receptors (CARs) are essential for converting antigen recognition into antitumoural function. Although there are many possible combinations of ICDs, almost all current CARs rely on combinations of CD3𝛇, CD28 and 4-1BB. Here we show that a barcoded library of 700,000 unique CD19-specific CARs with diverse ICDs cloned into lentiviral vectors and transduced into Jurkat T cells can be screened at high throughput via cell sorting and next-generation sequencing to optimize CAR signalling for antitumoural functions. By using this screening approach, we identified CARs with new ICD combinations that, compared with clinically available CARs, endowed human primary T cells with comparable tumour control in mice and with improved proliferation, persistence, exhaustion and cytotoxicity after tumour rechallenge in vitro. The screening strategy can be adapted to other disease models, cell types and selection conditions, and could be used to improve adoptive cell therapies and to expand their utility to new disease indications.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Animals / Humans Idioma: En Revista: Nat Biomed Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Animals / Humans Idioma: En Revista: Nat Biomed Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
...